Delivery Order SPE2DB22D2211-SPE2DB25FSESM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,061.31 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream 15GM on September 8, 2025, with completion expected by September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.97 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on August 29, 2025, with an ultimate completion date of September 2, 2025. The contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, with a contract ceiling value of $5,614.00 and a firm fixed price. The award was competitively procured without set-aside designation and is scheduled for completion by August 22, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.03 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work at its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- This is a $2,093.60 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream 15GM. The order has a period of performance ending on September 25, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units with a ceiling value of $2,633.58. This firm fixed price contract, awarded on September 9, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 10, 2025. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This delivery order is issued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Mupirocin 2% Cream in 30 gram units, with a ceiling value of $1,341.38 and a final completion date of September 20, 2024. The contract is a Firm Fixed Price type and is not set aside for any specific business categories. Amerisourcebergen, a major pharmaceutical distributor, is the prime...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,788.68 firm-fixed-price contract is for the supply of 4,565,426,384 units of Mupirocin 2% cream, a topical antibiotic ointment, with a period of performance through August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an existing Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award, valued at $1,704.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.14 firm-fixed-price delivery order is for the supply of 4554785500 - Mupirocin 2% Cream 15GM, with a completion date of September 15, 2021. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSESMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,416.28 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram units on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mupirocin is a topical antibiotic commonly used for treating bacterial skin infections and is a standard pharmaceutical commodity within military and federal healthcare supply chains. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and the Defense Health Agency. The parent IDC represents a global pharmaceutical support vehicle enabling flexible fulfillment of federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/10/25 |